Air Cargo Pharmaceutical Cold Chain Data Logger Market Size, Trends & Growth Opportunity By Data Logger Type, By Cargo Application, By Compliance Standard, By Region and Forecast Till 2030

Report ID : AMR1006209 | Industries : Healthcare | Published On :September 2026 | Page Count : 219

Request Sample
Ask for Customization

The global air cargo pharmaceutical cold chain data logger market covers portable and connected monitoring devices used to record temperature, humidity, pressure, shock and vibration, light exposure and location during the air freight transport of pharmaceutical and healthcare cargo.

An air cargo data logger is a monitoring device attached to or packed with a shipment, and this report describes the category strictly as a market segment, never as flight recording or avionics equipment fitted to the aircraft itself.

It makes no claim about clinical efficacy, treatment outcome, pharmacovigilance or drug, vaccine or therapy effectiveness for any product or company described on these pages.

Seven segmentation dimensions appear in this report, and the first two describe the data logger type supplied and the monitoring parameter it tracks.

Data logger type spans seven categories, from single-use and reusable air cargo data loggers through wireless, Bluetooth-enabled and cellular connected loggers to GPS-integrated and multi-parameter loggers.

Monitoring parameter covers seven categories, including temperature, humidity, pressure, shock and vibration, light exposure, location tracking and combined environmental monitoring.

The most useful commercial observation about this market is that shipment reversibility, not monitoring parameter alone, is the first specification decision a buyer actually makes.

Whether a device can realistically be retrieved and returned after a one-way international air shipment determines whether single-use or reusable logger categories are even viable before monitoring parameter or connectivity is considered.

Deployment model spans four categories and commercial model spans a further four, covering standalone devices, cloud-connected monitoring systems, integrated compliance platforms and end-to-end monitoring-as-a-service, sold through device sales, subscription monitoring platforms, monitoring and calibration bundles and managed compliance services.

Compliance standard covers five named categories, including GDP-compliant monitoring, GMP-compliant monitoring, FDA 21 CFR Part 11 compliant systems, IATA CEIV Pharma compatible solutions and ISO 17025 traceable systems.

Cargo application is the widest dimension in this report at eight categories, spanning pharmaceuticals, vaccines, cell and gene therapies, clinical trial materials, biologics, blood products, diagnostic materials and high-value healthcare products.

End user spans a further eight categories, including pharmaceutical manufacturers, biotechnology companies, contract manufacturing organisations, air cargo operators, freight forwarders, 3PL cold chain providers, healthcare logistics providers and airport pharma handling facilities.

This report covers air cargo data loggers used to monitor pharmaceutical and healthcare cargo moving by air freight across Europe, North America, Asia-Pacific, Latin America and the Middle East and Africa.

It excludes aircraft flight data recorders, cockpit voice recorders, avionics black boxes and any aircraft-system flight-safety recording equipment entirely.

Buyer intelligence in the full report maps global pharma manufacturers, specialty biotech companies, vaccine developers and clinical research organisations across all five regions, alongside a dedicated strategic relevance assessment for pharma-focused cold chain monitoring specialists.

Competitive benchmarking compares suppliers across estimated market position, installed base, pricing tiers, distribution reach and four further metrics without disclosing proprietary competitive positioning data.

Market Size & Growth Forecast (2026 to 2030)

The global air cargo pharmaceutical cold chain data logger market is estimated at approximately USD 285 Million in 2025 and is projected to reach approximately USD 535 Million by 2030, expanding at a compound annual growth rate of roughly 13.4 percent.

The estimate covers air cargo data loggers used to monitor pharmaceutical and healthcare cargo in transit, and excludes aircraft flight data recorders and general cold chain monitoring hardware used in storage, road or sea transport.

Single-use air cargo data loggers account for the largest data logger type category by revenue, reflecting their established position across one-way international pharmaceutical shipments, while multi-parameter data loggers form the fastest-growing data logger type category.

Temperature monitoring accounts for the largest monitoring parameter category by volume, and combined environmental monitoring forms the fastest-growing parameter category as buyers increasingly specify temperature, humidity and shock tracking in a single device.

Standalone devices account for the largest deployment model category by installed base, and cloud-connected monitoring systems form a fast-growing deployment category tied to the shift toward live, in-transit visibility.

GDP-compliant monitoring accounts for the largest compliance standard category, reflecting its position as the baseline distribution-practice requirement across nearly every shipment this report tracks, while IATA CEIV Pharma compatible solutions form a fast-growing compliance category tied to expanding certified air cargo corridors.

Pharmaceuticals account for the largest cargo application category by revenue, while cell and gene therapies form the fastest-growing cargo application category tracked in this report.

Pharmaceutical manufacturers account for the largest end user category, and 3PL cold chain providers form a fast-growing end user category as monitoring programme ownership increasingly shifts toward specialist logistics partners.

Europe accounts for the largest regional concentration in this report, and Asia-Pacific forms the fastest-growing region tied to expanding biopharmaceutical manufacturing and vaccine production capacity.

The forecast assumes continued growth in global air cargo capacity for temperature-sensitive healthcare shipments, and a sustained slowdown in pharmaceutical air freight volume would move the trajectory.

MetricValue
Market Size (2025)Approximately USD 285 Million
Forecast Size (2030)Approximately USD 535 Million
CAGR (2025-2030)Approximately 13.4%
Base Year2025
Forecast Period2026-2030 (5-year)
Scope NoteAir cargo data loggers for pharmaceutical and healthcare cold chain cargo only; excludes aircraft flight data recorders and general storage, road or sea cold chain monitoring hardware
Largest Data Logger TypeSingle-use air cargo data loggers
Fastest-Growing Data Logger TypeMulti-parameter data loggers
Largest Cargo ApplicationPharmaceuticals
Fastest-Growing Cargo ApplicationCell and gene therapies
Largest Compliance CategoryGDP-compliant monitoring
Largest Regional ConcentrationEurope

 

Market Drivers

Expansion of global vaccine, biologics, cell and gene therapy manufacturing and distribution, all of which require continuous temperature, humidity and shock monitoring across air cargo transit.

Rising regulatory audit activity and GDP certification initiatives among pharmaceutical manufacturers and logistics providers, driving systematic adoption of compliant data logger programmes.

Growth in digital transformation projects and IoT-enabled compliance platforms, shifting demand from standalone offline loggers toward cloud-connected and managed monitoring services.

Expansion of dedicated airline pharma corridor capacity and IATA CEIV Pharma-certified trade lanes, broadening the air cargo network over which temperature-sensitive healthcare cargo moves.

Increasing frequency of reported cold chain failures and excursion incidents, reinforcing buyer willingness to pay for more reliable, better-documented monitoring devices.

Growth in biologics and blood product air shipment volume, broadening data logger demand beyond vaccines and clinical trial materials alone.

Rising adoption of multi-parameter loggers that combine temperature, humidity, shock and location tracking in a single device, reducing the number of separate devices a shipment must carry.

Expansion of contract manufacturing organisation and biotechnology company air shipment activity, widening the end-user base beyond large pharmaceutical manufacturers alone.

Growth in airport pharma handling facility certification programmes, which increasingly specify a minimum data logger standard for cargo accepted into their facilities.

Market Restraints

Device and monitoring-platform cost pressure from price-sensitive freight forwarders and 3PL cold chain providers operating on thin logistics margins.

Fragmentation across multiple overlapping compliance standards (GDP, GMP, FDA 21 CFR Part 11, IATA CEIV Pharma and ISO 17025), raising the documentation and certification burden on both device manufacturers and logistics buyers.

Distributor ecosystem complexity across air cargo operators, freight forwarders and specialty 3PL cold chain providers, which fragments the go-to-market path for any single monitoring technology.

Dependence on continued growth in global air cargo capacity for temperature-sensitive healthcare shipments, a mode of transport exposed to broader airline network and fuel-cost volatility outside any monitoring provider's control.

Single-use logger disposal and environmental considerations, which some buyers increasingly weigh against reusable device total cost of ownership.

Calibration and traceability documentation burden for ISO 17025-aligned programmes, which raises ongoing operating cost beyond the initial device purchase.

Variation in airline and ground-handler acceptance procedures for data logger-equipped shipments across different airport pharma handling facilities.

Competition between pharma-focused cold chain specialists, broader industrial monitoring manufacturers and newer supply chain visibility providers, which fragments technical and commercial preference.

PROCUREMENT INSIGHT

Quality directors and GDP compliance managers increasingly qualify a monitoring supplier against the full five-standard compliance chain well before a specific shipment programme is signed, meaning fragmentation across GDP, GMP, FDA 21 CFR Part 11, IATA CEIV Pharma and ISO 17025 functions as a genuine barrier to entry rather than a one-time onboarding cost.

 

Market Opportunities

Considerable untapped opportunity identified in the high-compliance segment gap analysis, where fewer providers maintain the full breadth of GDP, GMP, FDA 21 CFR Part 11 and IATA CEIV Pharma-aligned capability.

Underpenetrated pharma air cargo corridors outside the most established transatlantic and transpacific lanes, where monitoring programme adoption still lags shipment growth.

Emerging cell and gene therapy logistics opportunities, a cargo category with the tightest temperature tolerance and fastest growth trajectory of any application tracked in this report.

Considerable untapped opportunity among previously overlooked customer segments identified in the competitive mapping, particularly among mid-sized biotechnology companies and contract manufacturing organisations without an established monitoring programme.

Growth in managed compliance services and end-to-end monitoring-as-a-service models, which several suppliers are using to differentiate from standard device-sales relationships.

Expansion of multi-parameter and GPS-integrated logger portfolios, which reduces the number of separate qualification processes a buyer must maintain.

Growth in airport pharma handling facility certification activity, creating a new institutional buyer category for device and platform suppliers.

Growing demand from 3PL cold chain providers assembling their own monitoring programmes for multiple pharmaceutical manufacturer clients, rather than relying on a single manufacturer's device choice.

MARKET SHIFT

Cell and gene therapy logistics is shifting from a niche cargo category toward a mainstream specification driver even as it remains this market's fastest-growing cargo application, pulling supplier investment toward multi-parameter and GPS-integrated devices faster than the broader pharmaceuticals category requires.

 

Data Logger Types and Monitoring Parameters

Buyers evaluating data logger types and monitoring parameters increasingly weigh shipment reversibility alongside connectivity when narrowing a shortlist, since single-use, reusable, wireless, Bluetooth-enabled, cellular connected, GPS-integrated and multi-parameter loggers are supplied across temperature, humidity, pressure, shock and vibration, light exposure, location tracking and combined environmental monitoring parameters.

Deployment Models and Commercial Models

Standalone, cloud-connected, integrated compliance and end-to-end monitoring-as-a-service deployment and commercial models are sold through device sales, subscription monitoring platforms, monitoring and calibration bundles and managed compliance services, and the resulting deployment and commercial model pairing often determines which suppliers a buyer can shortlist for a given programme.

Compliance Standards

GDP-compliant, GMP-compliant, FDA 21 CFR Part 11 compliant, IATA CEIV Pharma compatible and ISO 17025 traceable systems make up the air cargo cold chain compliance standards this market tracks, and which standard a shipment must satisfy is set by its lifecycle position rather than by airline or forwarder preference.

Cargo Applications and End Users

Pharmaceuticals, vaccines, cell and gene therapies, clinical trial materials, biologics, blood products, diagnostic materials and high-value healthcare products move through pharmaceutical manufacturers, biotechnology companies, contract manufacturing organisations, air cargo operators, freight forwarders, 3PL cold chain providers, healthcare logistics providers and airport pharma handling facilities, and this spread of cargo applications and end users shapes which device and compliance combination a given shipment ultimately requires.

Air Cargo Cold Chain Data Logger Market, By Region

This report covers Europe, North America, Asia-Pacific, Latin America and the Middle East and Africa, reflecting where global air cargo pharmaceutical and healthcare logistics activity is concentrated.

Europe accounts for the largest regional concentration in this report, covered through Denmark, Germany, the United Kingdom, France, the Netherlands, Switzerland, Italy and Spain, with activity concentrated around established pharmaceutical manufacturing hubs and GDP-aligned distribution networks.

North America represents a steady, established regional concentration, covered through the United States and Canada, with demand tied to biologics, vaccine and clinical trial material air shipment volume.

Asia-Pacific forms the fastest-growing regional concentration in this report, covered through China, Japan, India, Singapore, South Korea and Australia, tied to expanding biopharmaceutical manufacturing and vaccine production capacity.

Latin America and the Middle East and Africa represent earlier-stage regional concentrations in this report, covered through Brazil and Mexico, and the UAE, Saudi Arabia and South Africa respectively, with demand tied to growing healthcare logistics infrastructure and airport pharma handling facility investment.

Regional sizing, growth rates and country-level breakdowns are reserved for the full report rather than presented on this page.

Leading Companies

Sensitech, Controlant, Berlinger and Co. AG, ELPRO, Dickson, Testo SE and Co. KGaA, Tive, Infratab, DeltaTrak, Temptime Corporation, SpotSee, Emerson, Monnit, Hanwell Solutions and Eupry are covered in the full report. An introduction to the supplier landscape by company type is available on the leading air cargo cold chain data logger companies page.

Beyond This Page

The full report extends well past the segmentation summarised here and into the commercial detail that shapes how air cargo cold chain data logger supply is actually won.

Buyer intelligence maps the buyer ecosystem across global pharma manufacturers, specialty biotech companies, vaccine developers and clinical research organisations in full, including a dedicated strategic relevance assessment for pharma-focused cold chain monitoring specialists.

Decision-maker mapping covers budget ownership, vendor selection criteria, contract value bands and typical sales cycle duration.

Competitive benchmarking compares suppliers across installed base, pricing tiers, distribution reach, regulatory credentials and platform integration strength.

The market playbook covers pricing and cost structure analysis, regulatory compliance evolution, distributor ecosystem evolution and IoT and digital compliance trends.

Pricing and procurement chapters cover data logger pricing analysis, SaaS monitoring platform pricing, calibration service pricing and total cost of ownership assessment.

Go-to-market chapters set out direct sales strategy, channel partner strategy, aviation logistics partnerships and pharmaceutical supply chain partnerships.

Company profiles cover fifteen companies across geographic footprint, product portfolio, aviation monitoring offerings, compliance capabilities and certifications.

Frequently Asked Questions

The market is estimated at approximately USD 285 Million in 2025 and is projected to reach approximately USD 535 Million by 2030, expanding at a compound annual growth rate of roughly 13.4 percent.

A monitoring device attached to or packed with a pharmaceutical or healthcare shipment to record conditions such as temperature, humidity, pressure, shock and vibration, light exposure or location during air freight transport. This report describes the category strictly as a market segment, never as aircraft flight recording equipment.

Expansion of global vaccine, biologics, cell and gene therapy manufacturing and distribution is the leading driver, alongside rising regulatory audit activity and GDP certification initiatives among pharmaceutical manufacturers and logistics providers.

Europe accounts for the largest regional concentration, covered through Denmark, Germany, the United Kingdom, France, the Netherlands, Switzerland, Italy and Spain, with activity concentrated around established pharmaceutical manufacturing hubs and GDP-aligned distribution networks.

Single-use loggers are generally specified for one-way international shipments where device return is impractical, while reusable loggers are generally specified where a shipment route supports a closed-loop return process, a distinction that affects which commercial model a buyer typically adopts.

GDP-compliant monitoring, GMP-compliant monitoring, FDA 21 CFR Part 11 compliant systems, IATA CEIV Pharma compatible solutions and ISO 17025 traceable systems are the five named categories this report tracks, each governing a different point in the shipment lifecycle.

Pharmaceuticals generate the largest share of demand by revenue, while cell and gene therapies form the fastest-growing cargo application category given their unusually tight temperature tolerance and rapid underlying growth.

Pharmaceutical manufacturers account for the largest end user category, alongside biotechnology companies, contract manufacturing organisations, air cargo operators, freight forwarders, 3PL cold chain providers, healthcare logistics providers and airport pharma handling facilities.

Inquire Before Buying Request Free Sample Ask For Discount

1. Introduction

1.1. Objective of the Study

1.2. Market Definition

1.3. Market Scope

2. Executive Summary

3. Airplane Data Logger Market Analysis and Forecast (2026–2030)

3.1. Overview

3.2. Market Dynamics

3.3. Drivers

3.3.1. Expansion of Global Vaccine, Biologics, Cell and Gene Therapy Manufacturing and Distribution, All of Which Require Continuous Temperature, Humidity and Shock Monitoring Across Air Cargo Transit.

3.3.2. Rising Regulatory Audit Activity and GDP Certification Initiatives Among Pharmaceutical Manufacturers and Logistics Providers, Driving Systematic Adoption of Compliant Data Logger Programmes.

3.3.3. Growth in Digital Transformation Projects and IoT-Enabled Compliance Platforms, Shifting Demand from Standalone Offline Loggers Toward Cloud-Connected and Managed Monitoring Services.

3.3.4. Expansion of Dedicated Airline Pharma Corridor Capacity and IATA CEIV Pharma-Certified Trade Lanes, Broadening the Air Cargo Network Over Which Temperature-Sensitive Healthcare Cargo Moves.

3.3.5. Increasing Frequency of Reported Cold Chain Failures and Excursion Incidents, Reinforcing Buyer Willingness to Pay for More Reliable, Better-Documented Monitoring Devices.

3.4. Restraints

3.4.1. Device and Monitoring-Platform Cost Pressure from Price-Sensitive Freight Forwarders and 3PL Cold Chain Providers Operating on Thin Logistics Margins.

3.4.2. Fragmentation Across Multiple Overlapping Compliance Standards (GDP, GMP, FDA 21 CFR Part 11, IATA CEIV Pharma and ISO 17025), Raising the Documentation and Certification Burden on Both Device Manufacturers and Logistics Buyers.

3.4.3. Distributor Ecosystem Complexity Across Air Cargo Operators, Freight Forwarders and Specialty 3PL Cold Chain Providers, Which Fragments the Go-to-Market Path for Any Single Monitoring Technology.

3.4.4. Dependence on Continued Growth in Global Air Cargo Capacity for Temperature-Sensitive Healthcare Shipments, a Mode of Transport Exposed to Broader Airline Network and Fuel-Cost Volatility Outside Any Monitoring Provider's Control.

3.5. Opportunities

3.5.1. Considerable Untapped Opportunity Identified in the High-Compliance Segment Gap Analysis, Where Fewer Providers Maintain the Full Breadth of GDP, GMP, FDA 21 CFR Part 11 and IATA CEIV Pharma-Aligned Capability.

3.5.2. Underpenetrated Pharma Air Cargo Corridors Outside the Most Established Transatlantic and Transpacific Lanes, Where Monitoring Programme Adoption Still Lags Shipment Growth.

3.5.3. Emerging Cell and Gene Therapy Logistics Opportunities, a Cargo Category with the Tightest Temperature Tolerance and Fastest Growth Trajectory of Any Application Tracked in This Report.

3.5.4. Considerable Untapped Opportunity Among White-Space Customer Segments Identified in the Competitive Mapping, Particularly Among Mid-Sized Biotechnology Companies and Contract Manufacturing Organisations Without an Established Monitoring Programme.

3.6. Porter's Five Forces Model

3.7. Value Chain Analysis

4. Data Logger Type

4.1. Single-Use Air Cargo Data Loggers

4.2. Reusable Data Loggers

4.3. Wireless Data Loggers

4.4. Bluetooth-Enabled Data Loggers

4.5. Cellular Connected Data Loggers

4.6. GPS-Integrated Data Loggers

4.7. Multi-Parameter Data Loggers

5. Monitoring Parameter

5.1. Temperature

5.2. Humidity

5.3. Pressure

5.4. Shock and Vibration

5.5. Light Exposure

5.6. Location Tracking

5.7. Combined Environmental Monitoring

6. Deployment Model

6.1. Standalone Devices

6.2. Cloud-Connected Monitoring Systems

6.3. Integrated Compliance Platforms

6.4. End-to-End Monitoring-as-a-Service

7. Compliance Standard

7.1. GDP-Compliant Monitoring

7.2. GMP-Compliant Monitoring

7.3. FDA 21 CFR Part 11 Compliant Systems

7.4. IATA CEIV Pharma Compatible Solutions

7.5. ISO 17025 Traceable Systems

8. Cargo Application

8.1. Pharmaceuticals

8.2. Vaccines

8.3. Cell and Gene Therapies

8.4. Clinical Trial Materials

8.5. Biologics

8.6. Blood Products

8.7. Diagnostic Materials

8.8. High-Value Healthcare Products

9. End User

9.1. Pharmaceutical Manufacturers

9.2. Biotechnology Companies

9.3. Contract Manufacturing Organisations

9.4. Air Cargo Operators

9.5. Freight Forwarders

9.6. 3PL Cold Chain Providers

9.7. Healthcare Logistics Providers

9.8. Airport Pharma Handling Facilities

10. Commercial Model

10.1. Device Sales

10.2. Subscription Monitoring Platforms

10.3. Monitoring and Calibration Bundles

10.4. Managed Compliance Services

11. Buyer Intelligence and Demand Landscape

11.1. Buyer Segmentation

11.1.1. Global Pharma Manufacturers

11.1.2. Specialty Biotech Companies

11.1.3. Vaccine Developers

11.1.4. Clinical Research Organisations

11.1.5. Air Cargo Operators

11.1.6. Cold Chain Logistics Providers

11.2. Buyer Industries

11.2.1. Pharmaceuticals

11.2.2. Biotechnology

11.2.3. Healthcare Logistics

11.2.4. Clinical Research

11.2.5. Specialty Healthcare Distribution

11.3. Buyer Company Types

11.3.1. Multinational Enterprises

11.3.2. Regional Logistics Providers

11.3.3. Specialty Cold Chain Operators

11.3.4. Government Healthcare Agencies

11.4. Buyer Mapping

11.4.1. Country-Wise Buyer Mapping

11.4.2. Regional Demand Clusters

11.5. Buyer Scale Classification

11.5.1. Enterprise

11.5.2. Mid-Market

11.5.3. Emerging Operators

11.6. Procurement Models

11.6.1. Direct Procurement

11.6.2. Global Framework Agreements

11.6.3. Logistics Partner Bundling

11.6.4. Distributor Procurement

11.7. Buying Triggers

11.7.1. Regulatory Audits

11.7.2. Cold Chain Failures

11.7.3. GDP Certification Initiatives

11.7.4. Digital Transformation Projects

11.7.5. Airline Pharma Corridor Expansion

11.8. Decision Makers

11.8.1. Quality Directors

11.8.2. GDP Compliance Managers

11.8.3. Supply Chain Directors

11.8.4. Logistics Directors

11.8.5. Validation Managers

11.8.6. Procurement Leaders

11.8.7. Budget Ownership

11.8.8. Vendor Selection Criteria

11.8.9. Contract Value Bands

11.8.10. Typical Sales Cycle Duration

11.9. Strategic Relevance Assessment

11.9.1. Strategic Relevance Assessment for Dedicated Pharma Cold Chain Monitoring Specialists

12. By Region

12.1. Europe

12.2. North America

12.3. Asia-Pacific

12.4. Latin America

12.5. Middle East and Africa

13. Europe Airplane Data Logger Market - Global View of Air Cargo Cold Chain Data Loggers for Pharmaceutical and Healthcare Logistics with Spotlight on Monitoring Parameters, Deployment Models, Compliance Standards, Cargo Applications, End Users, Buyer Intelligence, Competitive Benchmarking and Growth Opportunity Analysis Market Analysis and Forecast (2026–2030)

13.1. Introduction

13.2. Market Share Analysis

13.3. Market Size and Forecast

13.4. Market Size and Forecast, By Geography

13.4.1. Denmark

13.4.1.1. Market Share Analysis

13.4.1.2. Market Size and Forecast

13.4.1.3. By Product

13.4.1.4. By Technology

13.4.1.5. By Application

13.4.1.6. By Customer

13.4.2. Germany

13.4.2.1. Market Share Analysis

13.4.2.2. Market Size and Forecast

13.4.2.3. By Product

13.4.2.4. By Technology

13.4.2.5. By Application

13.4.2.6. By Customer

13.4.3. United Kingdom

13.4.3.1. Market Share Analysis

13.4.3.2. Market Size and Forecast

13.4.3.3. By Product

13.4.3.4. By Technology

13.4.3.5. By Application

13.4.3.6. By Customer

13.4.4. France

13.4.4.1. Market Share Analysis

13.4.4.2. Market Size and Forecast

13.4.4.3. By Product

13.4.4.4. By Technology

13.4.4.5. By Application

13.4.4.6. By Customer

13.4.5. Netherlands

13.4.5.1. Market Share Analysis

13.4.5.2. Market Size and Forecast

13.4.5.3. By Product

13.4.5.4. By Technology

13.4.5.5. By Application

13.4.5.6. By Customer

13.4.6. Switzerland

13.4.6.1. Market Share Analysis

13.4.6.2. Market Size and Forecast

13.4.6.3. By Product

13.4.6.4. By Technology

13.4.6.5. By Application

13.4.6.6. By Customer

13.4.7. Italy

13.4.7.1. Market Share Analysis

13.4.7.2. Market Size and Forecast

13.4.7.3. By Product

13.4.7.4. By Technology

13.4.7.5. By Application

13.4.7.6. By Customer

13.4.8. Spain

13.4.8.1. Market Share Analysis

13.4.8.2. Market Size and Forecast

13.4.8.3. By Product

13.4.8.4. By Technology

13.4.8.5. By Application

13.4.8.6. By Customer

14. North America Airplane Data Logger Market - Global View of Air Cargo Cold Chain Data Loggers for Pharmaceutical and Healthcare Logistics with Spotlight on Monitoring Parameters, Deployment Models, Compliance Standards, Cargo Applications, End Users, Buyer Intelligence, Competitive Benchmarking and Growth Opportunity Analysis Market Analysis and Forecast (2026–2030)

14.1. Introduction

14.2. Market Share Analysis

14.3. Market Size and Forecast

14.4. Market Size and Forecast, By Geography

14.4.1. United States

14.4.1.1. Market Share Analysis

14.4.1.2. Market Size and Forecast

14.4.1.3. By Product

14.4.1.4. By Technology

14.4.1.5. By Application

14.4.1.6. By Customer

14.4.2. Canada

14.4.2.1. Market Share Analysis

14.4.2.2. Market Size and Forecast

14.4.2.3. By Product

14.4.2.4. By Technology

14.4.2.5. By Application

14.4.2.6. By Customer

15. Asia-Pacific Airplane Data Logger Market - Global View of Air Cargo Cold Chain Data Loggers for Pharmaceutical and Healthcare Logistics with Spotlight on Monitoring Parameters, Deployment Models, Compliance Standards, Cargo Applications, End Users, Buyer Intelligence, Competitive Benchmarking and Growth Opportunity Analysis Market Analysis and Forecast (2026–2030)

15.1. Introduction

15.2. Market Share Analysis

15.3. Market Size and Forecast

15.4. Market Size and Forecast, By Geography

15.4.1. China

15.4.1.1. Market Share Analysis

15.4.1.2. Market Size and Forecast

15.4.1.3. By Product

15.4.1.4. By Technology

15.4.1.5. By Application

15.4.1.6. By Customer

15.4.2. Japan

15.4.2.1. Market Share Analysis

15.4.2.2. Market Size and Forecast

15.4.2.3. By Product

15.4.2.4. By Technology

15.4.2.5. By Application

15.4.2.6. By Customer

15.4.3. India

15.4.3.1. Market Share Analysis

15.4.3.2. Market Size and Forecast

15.4.3.3. By Product

15.4.3.4. By Technology

15.4.3.5. By Application

15.4.3.6. By Customer

15.4.4. Singapore

15.4.4.1. Market Share Analysis

15.4.4.2. Market Size and Forecast

15.4.4.3. By Product

15.4.4.4. By Technology

15.4.4.5. By Application

15.4.4.6. By Customer

15.4.5. South Korea

15.4.5.1. Market Share Analysis

15.4.5.2. Market Size and Forecast

15.4.5.3. By Product

15.4.5.4. By Technology

15.4.5.5. By Application

15.4.5.6. By Customer

15.4.6. Australia

15.4.6.1. Market Share Analysis

15.4.6.2. Market Size and Forecast

15.4.6.3. By Product

15.4.6.4. By Technology

15.4.6.5. By Application

15.4.6.6. By Customer

16. Latin America Airplane Data Logger Market - Global View of Air Cargo Cold Chain Data Loggers for Pharmaceutical and Healthcare Logistics with Spotlight on Monitoring Parameters, Deployment Models, Compliance Standards, Cargo Applications, End Users, Buyer Intelligence, Competitive Benchmarking and Growth Opportunity Analysis Market Analysis and Forecast (2026–2030)

16.1. Introduction

16.2. Market Share Analysis

16.3. Market Size and Forecast

16.4. Market Size and Forecast, By Geography

16.4.1. Brazil

16.4.1.1. Market Share Analysis

16.4.1.2. Market Size and Forecast

16.4.1.3. By Product

16.4.1.4. By Technology

16.4.1.5. By Application

16.4.1.6. By Customer

16.4.2. Mexico

16.4.2.1. Market Share Analysis

16.4.2.2. Market Size and Forecast

16.4.2.3. By Product

16.4.2.4. By Technology

16.4.2.5. By Application

16.4.2.6. By Customer

17. Middle East and Africa Airplane Data Logger Market - Global View of Air Cargo Cold Chain Data Loggers for Pharmaceutical and Healthcare Logistics with Spotlight on Monitoring Parameters, Deployment Models, Compliance Standards, Cargo Applications, End Users, Buyer Intelligence, Competitive Benchmarking and Growth Opportunity Analysis Market Analysis and Forecast (2026–2030)

17.1. Introduction

17.2. Market Share Analysis

17.3. Market Size and Forecast

17.4. Market Size and Forecast, By Geography

17.4.1. UAE

17.4.1.1. Market Share Analysis

17.4.1.2. Market Size and Forecast

17.4.1.3. By Product

17.4.1.4. By Technology

17.4.1.5. By Application

17.4.1.6. By Customer

17.4.2. Saudi Arabia

17.4.2.1. Market Share Analysis

17.4.2.2. Market Size and Forecast

17.4.2.3. By Product

17.4.2.4. By Technology

17.4.2.5. By Application

17.4.2.6. By Customer

17.4.3. South Africa

17.4.3.1. Market Share Analysis

17.4.3.2. Market Size and Forecast

17.4.3.3. By Product

17.4.3.4. By Technology

17.4.3.5. By Application

17.4.3.6. By Customer

18. Competition Analysis

18.1. Market Positioning Overview

18.1.1. Global and Regional Competitive Structure

18.1.2. Technology Positioning

18.1.3. Compliance Positioning

18.1.4. Service-Led and Device-Led Strategies

18.1.5. Premium and Value Pricing Models

18.2. Competitive Benchmarking Metrics

18.2.1. Estimated Market Position Assessment

18.2.2. Installed Base

18.2.3. Pricing Tiers

18.2.4. Distribution Reach

18.2.5. Regulatory Credentials

18.2.6. Service Infrastructure

18.2.7. Calibration Capabilities

18.2.8. Platform Integration Strength

18.3. Strategic Moves

18.3.1. Product Launches

18.3.2. Technology Partnerships

18.3.3. Airline Logistics Partnerships

18.3.4. Pharma Logistics Alliances

18.3.5. Compliance Platform Enhancements

18.3.6. Geographic Expansion Activities

18.4. Competitive Mapping & Gaps

18.4.1. High-Compliance Segment Gaps

18.4.2. Underpenetrated Pharma Corridors

18.4.3. Emerging Cell and Gene Therapy Logistics Opportunities

18.4.4. Considerable Untapped Opportunity in Customer Segments

18.4.5. Differentiation Opportunities

19. Company Profiles

19.1. Sensitech

19.1.1. Corporate Overview

19.1.2. Ownership Structure

19.1.3. Founding Year

19.1.4. Workforce Estimate

19.1.5. Geographic Footprint

19.1.6. Product Portfolio

19.1.7. Aviation Monitoring Offerings

19.1.8. Compliance Capabilities

19.1.9. Customer Segments

19.1.10. Distribution and Go-to-Market (GTM) Strategy

19.1.11. Financial Highlights

19.1.12. Certifications

19.1.13. Strategic Partnerships

19.1.14. R&D Initiatives

19.1.15. Recent Developments

19.1.16. SWOT Snapshot

19.2. Controlant

19.2.1. Corporate Overview

19.2.2. Ownership Structure

19.2.3. Founding Year

19.2.4. Workforce Estimate

19.2.5. Geographic Footprint

19.2.6. Product Portfolio

19.2.7. Aviation Monitoring Offerings

19.2.8. Compliance Capabilities

19.2.9. Customer Segments

19.2.10. Distribution and Go-to-Market (GTM) Strategy

19.2.11. Financial Highlights

19.2.12. Certifications

19.2.13. Strategic Partnerships

19.2.14. R&D Initiatives

19.2.15. Recent Developments

19.2.16. SWOT Snapshot

19.3. Berlinger and Co. AG

19.3.1. Corporate Overview

19.3.2. Ownership Structure

19.3.3. Founding Year

19.3.4. Workforce Estimate

19.3.5. Geographic Footprint

19.3.6. Product Portfolio

19.3.7. Aviation Monitoring Offerings

19.3.8. Compliance Capabilities

19.3.9. Customer Segments

19.3.10. Distribution and Go-to-Market (GTM) Strategy

19.3.11. Financial Highlights

19.3.12. Certifications

19.3.13. Strategic Partnerships

19.3.14. R&D Initiatives

19.3.15. Recent Developments

19.3.16. SWOT Snapshot

19.4. ELPRO

19.4.1. Corporate Overview

19.4.2. Ownership Structure

19.4.3. Founding Year

19.4.4. Workforce Estimate

19.4.5. Geographic Footprint

19.4.6. Product Portfolio

19.4.7. Aviation Monitoring Offerings

19.4.8. Compliance Capabilities

19.4.9. Customer Segments

19.4.10. Distribution and Go-to-Market (GTM) Strategy

19.4.11. Financial Highlights

19.4.12. Certifications

19.4.13. Strategic Partnerships

19.4.14. R&D Initiatives

19.4.15. Recent Developments

19.4.16. SWOT Snapshot

19.5. Dickson

19.5.1. Corporate Overview

19.5.2. Ownership Structure

19.5.3. Founding Year

19.5.4. Workforce Estimate

19.5.5. Geographic Footprint

19.5.6. Product Portfolio

19.5.7. Aviation Monitoring Offerings

19.5.8. Compliance Capabilities

19.5.9. Customer Segments

19.5.10. Distribution and Go-to-Market (GTM) Strategy

19.5.11. Financial Highlights

19.5.12. Certifications

19.5.13. Strategic Partnerships

19.5.14. R&D Initiatives

19.5.15. Recent Developments

19.5.16. SWOT Snapshot

19.6. Testo SE and Co. KGaA

19.6.1. Corporate Overview

19.6.2. Ownership Structure

19.6.3. Founding Year

19.6.4. Workforce Estimate

19.6.5. Geographic Footprint

19.6.6. Product Portfolio

19.6.7. Aviation Monitoring Offerings

19.6.8. Compliance Capabilities

19.6.9. Customer Segments

19.6.10. Distribution and Go-to-Market (GTM) Strategy

19.6.11. Financial Highlights

19.6.12. Certifications

19.6.13. Strategic Partnerships

19.6.14. R&D Initiatives

19.6.15. Recent Developments

19.6.16. SWOT Snapshot

19.7. Tive

19.7.1. Corporate Overview

19.7.2. Ownership Structure

19.7.3. Founding Year

19.7.4. Workforce Estimate

19.7.5. Geographic Footprint

19.7.6. Product Portfolio

19.7.7. Aviation Monitoring Offerings

19.7.8. Compliance Capabilities

19.7.9. Customer Segments

19.7.10. Distribution and Go-to-Market (GTM) Strategy

19.7.11. Financial Highlights

19.7.12. Certifications

19.7.13. Strategic Partnerships

19.7.14. R&D Initiatives

19.7.15. Recent Developments

19.7.16. SWOT Snapshot

19.8. Infratab

19.8.1. Corporate Overview

19.8.2. Ownership Structure

19.8.3. Founding Year

19.8.4. Workforce Estimate

19.8.5. Geographic Footprint

19.8.6. Product Portfolio

19.8.7. Aviation Monitoring Offerings

19.8.8. Compliance Capabilities

19.8.9. Customer Segments

19.8.10. Distribution and Go-to-Market (GTM) Strategy

19.8.11. Financial Highlights

19.8.12. Certifications

19.8.13. Strategic Partnerships

19.8.14. R&D Initiatives

19.8.15. Recent Developments

19.8.16. SWOT Snapshot

19.9. DeltaTrak

19.9.1. Corporate Overview

19.9.2. Ownership Structure

19.9.3. Founding Year

19.9.4. Workforce Estimate

19.9.5. Geographic Footprint

19.9.6. Product Portfolio

19.9.7. Aviation Monitoring Offerings

19.9.8. Compliance Capabilities

19.9.9. Customer Segments

19.9.10. Distribution and Go-to-Market (GTM) Strategy

19.9.11. Financial Highlights

19.9.12. Certifications

19.9.13. Strategic Partnerships

19.9.14. R&D Initiatives

19.9.15. Recent Developments

19.9.16. SWOT Snapshot

19.10. Temptime Corporation

19.10.1. Corporate Overview

19.10.2. Ownership Structure

19.10.3. Founding Year

19.10.4. Workforce Estimate

19.10.5. Geographic Footprint

19.10.6. Product Portfolio

19.10.7. Aviation Monitoring Offerings

19.10.8. Compliance Capabilities

19.10.9. Customer Segments

19.10.10. Distribution and Go-to-Market (GTM) Strategy

19.10.11. Financial Highlights

19.10.12. Certifications

19.10.13. Strategic Partnerships

19.10.14. R&D Initiatives

19.10.15. Recent Developments

19.10.16. SWOT Snapshot

19.11. SpotSee

19.11.1. Corporate Overview

19.11.2. Ownership Structure

19.11.3. Founding Year

19.11.4. Workforce Estimate

19.11.5. Geographic Footprint

19.11.6. Product Portfolio

19.11.7. Aviation Monitoring Offerings

19.11.8. Compliance Capabilities

19.11.9. Customer Segments

19.11.10. Distribution and Go-to-Market (GTM) Strategy

19.11.11. Financial Highlights

19.11.12. Certifications

19.11.13. Strategic Partnerships

19.11.14. R&D Initiatives

19.11.15. Recent Developments

19.11.16. SWOT Snapshot

19.12. Emerson

19.12.1. Corporate Overview

19.12.2. Ownership Structure

19.12.3. Founding Year

19.12.4. Workforce Estimate

19.12.5. Geographic Footprint

19.12.6. Product Portfolio

19.12.7. Aviation Monitoring Offerings

19.12.8. Compliance Capabilities

19.12.9. Customer Segments

19.12.10. Distribution and Go-to-Market (GTM) Strategy

19.12.11. Financial Highlights

19.12.12. Certifications

19.12.13. Strategic Partnerships

19.12.14. R&D Initiatives

19.12.15. Recent Developments

19.12.16. SWOT Snapshot

19.13. Monnit

19.13.1. Corporate Overview

19.13.2. Ownership Structure

19.13.3. Founding Year

19.13.4. Workforce Estimate

19.13.5. Geographic Footprint

19.13.6. Product Portfolio

19.13.7. Aviation Monitoring Offerings

19.13.8. Compliance Capabilities

19.13.9. Customer Segments

19.13.10. Distribution and Go-to-Market (GTM) Strategy

19.13.11. Financial Highlights

19.13.12. Certifications

19.13.13. Strategic Partnerships

19.13.14. R&D Initiatives

19.13.15. Recent Developments

19.13.16. SWOT Snapshot

19.14. Hanwell Solutions

19.14.1. Corporate Overview

19.14.2. Ownership Structure

19.14.3. Founding Year

19.14.4. Workforce Estimate

19.14.5. Geographic Footprint

19.14.6. Product Portfolio

19.14.7. Aviation Monitoring Offerings

19.14.8. Compliance Capabilities

19.14.9. Customer Segments

19.14.10. Distribution and Go-to-Market (GTM) Strategy

19.14.11. Financial Highlights

19.14.12. Certifications

19.14.13. Strategic Partnerships

19.14.14. R&D Initiatives

19.14.15. Recent Developments

19.14.16. SWOT Snapshot

19.15. Eupry

19.15.1. Corporate Overview

19.15.2. Ownership Structure

19.15.3. Founding Year

19.15.4. Workforce Estimate

19.15.5. Geographic Footprint

19.15.6. Product Portfolio

19.15.7. Aviation Monitoring Offerings

19.15.8. Compliance Capabilities

19.15.9. Customer Segments

19.15.10. Distribution and Go-to-Market (GTM) Strategy

19.15.11. Financial Highlights

19.15.12. Certifications

19.15.13. Strategic Partnerships

19.15.14. R&D Initiatives

19.15.15. Recent Developments

19.15.16. SWOT Snapshot

Frequently Asked Questions

The market is estimated at approximately USD 285 Million in 2025 and is projected to reach approximately USD 535 Million by 2030, expanding at a compound annual growth rate of roughly 13.4 percent.

A monitoring device attached to or packed with a pharmaceutical or healthcare shipment to record conditions such as temperature, humidity, pressure, shock and vibration, light exposure or location during air freight transport. This report describes the category strictly as a market segment, never as aircraft flight recording equipment.

Expansion of global vaccine, biologics, cell and gene therapy manufacturing and distribution is the leading driver, alongside rising regulatory audit activity and GDP certification initiatives among pharmaceutical manufacturers and logistics providers.

Europe accounts for the largest regional concentration, covered through Denmark, Germany, the United Kingdom, France, the Netherlands, Switzerland, Italy and Spain, with activity concentrated around established pharmaceutical manufacturing hubs and GDP-aligned distribution networks.

Single-use loggers are generally specified for one-way international shipments where device return is impractical, while reusable loggers are generally specified where a shipment route supports a closed-loop return process, a distinction that affects which commercial model a buyer typically adopts.

GDP-compliant monitoring, GMP-compliant monitoring, FDA 21 CFR Part 11 compliant systems, IATA CEIV Pharma compatible solutions and ISO 17025 traceable systems are the five named categories this report tracks, each governing a different point in the shipment lifecycle.

Pharmaceuticals generate the largest share of demand by revenue, while cell and gene therapies form the fastest-growing cargo application category given their unusually tight temperature tolerance and rapid underlying growth.

Pharmaceutical manufacturers account for the largest end user category, alongside biotechnology companies, contract manufacturing organisations, air cargo operators, freight forwarders, 3PL cold chain providers, healthcare logistics providers and airport pharma handling facilities.

Inquire Before Buying Request Free Sample Ask For Discount

Air cargo pharmaceutical data loggers separated from the much larger general cold chain monitoring market

Cold chain monitoring is frequently reported as one broad category spanning refrigerated storage, trucking and maritime reefer telematics, RFID and networking infrastructure, and food and beverage applications alongside pharmaceuticals. This estimate covers only portable air cargo data loggers (temperature, humidity, pressure, shock and vibration, light exposure and location) used to monitor pharmaceutical and healthcare cargo in air freight transit. The snapshot table states that boundary so the figure is not mistaken for the broader cold chain monitoring category or confused with aircraft flight data recorders.

Derivation from the cold chain monitoring devices and software market

Two independently published cold chain monitoring market reports converge closely for 2025: MarketsAndMarkets sizes the global cold chain monitoring market (hardware and software) at USD 8.31 Billion in 2025, reaching USD 15.04 Billion by 2030 at a 12.6 percent CAGR, explicitly naming 'Sensors and Data Loggers' as a hardware category and Pharmaceuticals and Healthcare as a named application, with Testo SE and Co. KGaA and Controlant hf. among its named key players. GMInsights sizes the same category at USD 7.2 Billion in 2025, with hardware accounting for around 60 percent of the total and Pharmaceutical and Healthcare the largest end-use segment at USD 5.3 Billion in 2025. Both sources name Testo and Controlant, two of this report's own fifteen covered companies, directly corroborating the category match.

Narrowing to data-logger hardware, pharmaceutical application, and the air cargo transport mode

Data loggers are one of several hardware categories alongside RFID, telematics and networking devices, but remain the most established and broadly deployed category for discrete-shipment compliance monitoring; an estimated 35 percent share of the hardware segment was applied. Pharmaceutical and healthcare application share was set at approximately 55 percent of data-logger demand, reflecting that food and beverage cold chain increasingly favours continuous IoT sensors over discrete loggers, while pharma's GDP and GMP compliance requirements keep discrete logger use disproportionately high. Air cargo carries a disproportionate share of the highest-value, most time- and temperature-critical pharmaceutical shipments (vaccines, biologics, cell and gene therapies, clinical trial materials, reflected directly in this report's own cargo application segmentation) despite representing a smaller share of total pharmaceutical shipment volume by weight than road or sea transport; an estimated 32 percent air-cargo-mode share of pharmaceutical data logger demand was applied. Layering these three narrowings over the converged USD 7.5 to 8 Billion devices-and-software base produces a global air cargo pharmaceutical data logger range of approximately USD 270 to 300 Million for 2025, and USD 285 Million was adopted near the midpoint.

Forecast basis and its principal sensitivity

The forecast to 2030 assumes continued GDP and GMP-driven compliance adoption and continued expansion of IATA CEIV Pharma-certified air cargo corridors, broadly consistent with the 12.1 to 12.6 percent CAGR range both triangulation sources report for the broader cold chain monitoring category, with a modest premium reflecting this segment's own faster-growing cell and gene therapy and multi-parameter logger mix. Cell and gene therapy logistics growth is the principal forecast sensitivity, given its extreme time and temperature criticality and near-total reliance on premium air freight relative to every other cargo application this report tracks.

Frequently Asked Questions

The market is estimated at approximately USD 285 Million in 2025 and is projected to reach approximately USD 535 Million by 2030, expanding at a compound annual growth rate of roughly 13.4 percent.

A monitoring device attached to or packed with a pharmaceutical or healthcare shipment to record conditions such as temperature, humidity, pressure, shock and vibration, light exposure or location during air freight transport. This report describes the category strictly as a market segment, never as aircraft flight recording equipment.

Expansion of global vaccine, biologics, cell and gene therapy manufacturing and distribution is the leading driver, alongside rising regulatory audit activity and GDP certification initiatives among pharmaceutical manufacturers and logistics providers.

Europe accounts for the largest regional concentration, covered through Denmark, Germany, the United Kingdom, France, the Netherlands, Switzerland, Italy and Spain, with activity concentrated around established pharmaceutical manufacturing hubs and GDP-aligned distribution networks.

Single-use loggers are generally specified for one-way international shipments where device return is impractical, while reusable loggers are generally specified where a shipment route supports a closed-loop return process, a distinction that affects which commercial model a buyer typically adopts.

GDP-compliant monitoring, GMP-compliant monitoring, FDA 21 CFR Part 11 compliant systems, IATA CEIV Pharma compatible solutions and ISO 17025 traceable systems are the five named categories this report tracks, each governing a different point in the shipment lifecycle.

Pharmaceuticals generate the largest share of demand by revenue, while cell and gene therapies form the fastest-growing cargo application category given their unusually tight temperature tolerance and rapid underlying growth.

Pharmaceutical manufacturers account for the largest end user category, alongside biotechnology companies, contract manufacturing organisations, air cargo operators, freight forwarders, 3PL cold chain providers, healthcare logistics providers and airport pharma handling facilities.

Inquire Before Buying Request Free Sample Ask For Discount